Literature DB >> 18214768

Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses.

Baris E Dayanc1, Sarah H Beachy, Julie R Ostberg, Elizabeth A Repasky.   

Abstract

The effects of hyperthermia on natural killer (NK) cell cytotoxicity against tumor cell targets are not yet fully understood. A more complete understanding of these effects could be important for maximizing the clinical benefits obtained by using hyperthermia for cancer therapy. Here, we summarize results in the literature regarding the effects of elevated temperatures on NK cells and our own recent data on the effects of fever-range temperatures. At treatment temperatures above 40 degrees C, (which is above the physiological body temperatures normally achieved during fever or exercise), both enhancing and inhibitory effects on cytotoxic activity of NK cells against tumor cells have been reported. Our own results have shown that fever-range thermal stress (using a temperature of 39.5 degrees C) enhances human NK cell cytotoxicity against tumor target cells. This effect requires function of the NKG2D receptor of NK cells, and is maximal when both NK and tumor cell targets are heated. Reported heat sensitive cellular targets affected by hyperthermia on tumor cells include heat shock proteins, MICA and MHC Class I. In NK cells, plasma membrane reorganization may occur after mild heat stress. We conclude this review by listing several unresolved questions that should be addressed for a more complete understanding of the molecular mechanisms which underlie the effects of thermal stress on the function of NK cells. Altogether, the available data indicate a strong potential for heat-induced enhancement of NK cell activity in mediating, at least in part, the improved clinical responses seen when hyperthermia is used in combination with other therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18214768     DOI: 10.1080/02656730701858297

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  24 in total

1.  A microfluidic platform for studying the effects of small temperature gradients in an incubator environment.

Authors:  Sarit K Das; Seok Chung; Ioannis Zervantonakis; Joseph Atnafu; Roger D Kamm
Journal:  Biomicrofluidics       Date:  2008-09-17       Impact factor: 2.800

2.  Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer.

Authors:  Sang-Won Kim; Ji Woon Yea; Jae Hwang Kim; Mi Jin Gu; Min Kyu Kang
Journal:  Int J Clin Oncol       Date:  2017-11-13       Impact factor: 3.402

Review 3.  Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?

Authors:  Chen-Ting Lee; Thomas Mace; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

4.  Mild Heat Treatment Primes Human CD34(+) Cord Blood Cells for Migration Toward SDF-1α and Enhances Engraftment in an NSG Mouse Model.

Authors:  Maegan L Capitano; Giao Hangoc; Scott Cooper; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

5.  Enhanced sensitivity of colon tumour cells to natural killer cell cytotoxicity after mild thermal stress is regulated through HSF1-mediated expression of MICA.

Authors:  Baris E Dayanc; Sanjay Bansal; Ali Osmay Gure; Sandra O Gollnick; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2013-08       Impact factor: 3.914

Review 6.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06

7.  The effect of thermochemotherapy with mitomycin C on normal bladder urothelium, an experimental study.

Authors:  Murat Uçar; Muammer Altok; Mehmet Umul; Dilek Bayram; İlkay Armağan; Mustafa Güneş; Tahsin Çapkin; Sedat Soyupek
Journal:  Int Urol Nephrol       Date:  2016-01       Impact factor: 2.370

8.  Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer.

Authors:  Ashish Ranjan; Compton J Benjamin; Ayele H Negussie; Saurin Chokshi; Paul H Chung; Dmitry Volkin; Nitin Yeram; W Marston Linehan; Matthew R Dreher; Peter A Pinto; Bradford J Wood
Journal:  Pharm Res       Date:  2016-06-24       Impact factor: 4.200

9.  Antitumor effect and immune response induced by local hyperthermia in B16 murine melanoma: Effect of thermal dose.

Authors:  Dan Ye Li; Yang Ping Tang; Ling Yun Zhao; Chuan Ying Geng; Jin Tian Tang
Journal:  Oncol Lett       Date:  2012-07-16       Impact factor: 2.967

Review 10.  Hyperthermia treatment advances for brain tumors.

Authors:  Georgios P Skandalakis; Daniel R Rivera; Caroline D Rizea; Alexandros Bouras; Joe Gerald Jesu Raj; Dominique Bozec; Constantinos G Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.